Tag Archives: calmare mc-5a

The importance of your Calmare Therapy provider’s expertise

April 12, 2013

By Dr. Michael J. Cooney, Director, Calmare Therapy NJ

Calmare Certified Location LogoI’ve received several patient queries lately about the expertise of the healthcare professional who is actually administering Calmare Therapy.  I’d like to touch on the importance of this question today─

Calmare is a “provider dependent” therapy

The scrambler therapy is performed by a “provider,” the specially-trained clinician who places each of the leads on the patient, sets the voltage, monitors response minute-by-minute and day-by-day, and makes ongoing adjustments based upon the patient’s response. In my practice, I am the provider, 100 percent of the time, from start to finish ─ no exceptions. The administering healthcare professional must have extensive expertisetraining and understanding to accurately diagnose the precise location of the pain site/s. This can be easier said than done.

Why? Because the placement of the leads (patches) which are attached to each of the algorithms must be precisely placed in order to alleviate pain. If these leads are placed in the wrong area, this lessens the overall capability of the Calmare MC-5A technology to optimally perform its job. I have served as a Trainer for the treatment for some new doctors introducing Calmare, and it is a responsibility I take very seriously.

What to look for in your Calmare provider

The most experienced Calmare Therapy providers have received a careful review and on-site examination by the company’s administrators who may or may not designate the top providers as Calmare Certified. I strongly encourage you to seek out these providers for your therapy. Secondly, ask the provider you are considering how many patients they have treated with your specific chronic pain condition ─ back and neck pain, post surgical pain, RSD / CRPS / fibromyalgia, pain after chemotherapy, diabetic neuropathy, etc.

Your Calmare technology will be most successful when your chosen provider has advanced expertise in the placement of each lead. In my opinion, this vitally important task should only be administered by a healthcare professional specifically trained in the diagnosis and treatment of several types of advanced neuropathy.

Chemotherapy-induced peripheral neuropathy (CIPN) patient begins Calmare Therapy

As we mentioned a few weeks ago, we welcomed our first Calmare Therapy patient from Europe (Amsterdam) this week who is undergoing treatment to combat chronic bilateral foot pain as a result of chemotherapy-induced peripheral neuropathy, or CIPN. As we and others have shared in the past, CIPN pain is notoriously difficult to treat successfully.

Our patient contracted CIPN three months after undergoing chemotherapy for breast cancer more than three years ago.  Her pain level escalated to a seven and she began having difficulty walking. She is undergoing 10 Calmare treatments and her outcome looks very positive. We look forward to sharing her outcome as she therapy progresses.

Dr. Michael Cooney

NEWS12 to Feature Dr. Michael Cooney and Calmare Therapy

Dr. Michael Cooney has just completed shooting a “To Your Health” with Dr. Derrick DeSilva segment for News12 where he discusses Calmare Pain Therapy Treatment. His patient, Laura Miller, an RSD and fibromyalgia sufferer for more than three years, also appeared on the program to discuss her condition, other painful and expensive chronic pain treatments that ultimately proved to be unsuccessful, and the final resolution of her pain after undergoing Calmare Therapy.

“News12 is one of the few television stations to prioritize healthcare news,” says Dr. Cooney. “They recognized the importance of informing viewers living with chronic pain that there is a new solution available to help these patients take control of their lives again.”

The Calmare Therapy segment featuring Dr. Cooney and Laura Miller will air January, 2012.

“Rewiring the Brain” article in the WSJ (11.15.11)

 By Dr. Michael J. Cooney, Rutherford Allied Medical Group

A colleague shared this important article from the Wall Street Journal,Rewiring the Brain to Ease Pain” that perfectly describes Calmare Therapy’s MC-5A technology, a pain-free and  drug free solution that rewires the brain’s messaging system.

How does Calmare work, in simple terms?

It distracts the patient from the pain and stimulates other areas of the brain by:

  • Activating the C fibers to the brain and taking “no pain” messages from adjacent areas and moving that artificial message through the spine to the brain.

The result?

What is the treatment protocol?

We administer 45-minute daily treatments over 10 consecutive days to “rewire” the malfunction in the brain’s pain processing pathways. 

The article references acupuncture treatments interrupting the pain signal. Calmare also interrupts the pain signal but uses various algorithms which does not permit the brain to accommodate and develop a tolerance to the stimulus.

Please remember we are treating long-term pain patients who have already tried other treatments, medications and therapies.  Calmare is not a placebo but a change in perception of what is felt at the local pain point–an analgesic approach which breaks the somatosensory cortex’s ability to feel the pain. It’s important to note that with most of our patients, it has been shown objectively, through a variety of tests, that the area of pain does not actually have any tissue damage. The pain is neurologically based.

Kudos to the Wall Street Journal for this exciting, accurate and relevant article in treating the “pain in the brain.”